Entities / Company
Boston Scientific.
worldwide developer, manufacturer and marketer of medical devices
- Reports this week
- 1
- Active events
- 1
- Connections
- 209
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
-
Mike Mahoney was appointed chairman and CEO of Boston Scientific on July 1, 2025.Well supported5 reports
-
Conavi Medical Corp. received FDA clearance for its system, which is used in the cardiovascular imaging sector.Some support1 report
-
Penumbra was acquired by Boston Scientific in a $14.5bn deal, and the company gained clearance for its Thunderbolt product line.Some support2 reports1 development inside
-
Shipping disruptions are causing procedural changes and increased competition among medical device manufacturers Johnson & Johnson and Boston Scientific.Some support2 reports
-
Both Dell Technologies and Boston Scientific were subject to analyst upgrades in May 2026.Some support1 report
-
Boston Scientific filed an incident report with the SEC regarding a cyberattack and hired CrowdStrike to investigate.Some support2 reports
-
Boston Scientific and NovoCure are both facing cybersecurity incidents in 2026.Some support1 report
-
David Gill, who holds an MBA from Emory University, was appointed Chair of Telix Board and previously worked for INC Research.Some support1 report
-
Stryker Corporation, Boston Scientific, and Medtronic plc are competing in the medical device market.Some support3 reports1 development inside
-
Boston Scientific is based in Massachusetts.Some support1 report
One to three months ago
-
Cyberattacks disrupted global operations of Boston Scientific, coinciding with the FDA raising concerns regarding product sheath tip separation.Some support4 reports
-
Boston Scientific announced major restructuring via filings with the NYSE and SEC on July 28, 2026.Well supported6 reports
-
Boston Scientific is headquartered in Marlboro, Massachusetts.Some support2 reports
-
Boston Scientific's global operations, based in Ireland, are affected across its facilities in Cork, Clonmel, and Galway.Some support2 reports
-
Morgan Stanley boosted its position in Boston Scientific shares, while the company's board authorized a stock repurchase program.Some support1 report
-
Raymond James Financial reissued an outperform rating and acquired a new position in Boston Scientific shares.Some support1 report
-
Royal Bank of Canada and Leerink Partners lowered price targets and ratings for Boston Scientific.Some support1 report
-
Norges Bank purchased a new position in shares of Boston Scientific.Some support1 report
-
Demand for the Watchman heart device manufactured by Boston Scientific has slowed sharply in the U.S., due to competitive market share losses.Some support1 report
-
A client successfully implemented leadership programs involving Boston Scientific, BTS Group AB, and Ernst & Young.Some support1 report
-
Companies founded by Robert Schwartz led to the acquisition of the Watchman device.Some support1 report
-
Analysts are comparing the business performance of two healthcare companies: Boston Scientific and Fielmann Group AG.Some support2 reports
-
The Child & Family Center was recognized for consistent support of children's services and sponsoring domestic violence and mental health programs.Some support2 reports
-
Gilead Sciences, Boston Scientific, McKesson Corporation, and Dexcom are listed as top medical stocks.Some support3 reports
-
Boston Scientific and TerrAscend compared their financial performance metrics on August 6, 2026.Some support1 report
-
Analyst questions regarding Boston Scientific influenced management's guidance reset due to competitive threats in the U.S. market.Some support1 report
-
Analyst downgrades and price target reductions affecting companies including GoDaddy, Boston Scientific, and Edison International.Some support1 report
-
Boston Scientific reported its financial results for the period ending August 2025, noting revenue increases across various regions.Some support3 reports
-
Boston Scientific and Avivagen are competing in the medical device market, with analysts using MarketBeat for ratings.Some support1 report1 development inside
-
MarketBeat highlighted Boston Scientific as a stock to watch on July 29, 2026.Some support4 reports
-
Ahmed Abdelaal has been appointed as CMO for Boston Scientific in the APAC region, and the company commissioned a report on AFib care there.Some support5 reports1 development inside
-
High confidence in PFA faces patient access gaps in the APAC healthcare market.Some support2 reports
-
Modular Medical, Inc., a San Diego-based medical device company, and Boston Scientific are both facing market scrutiny.Some support3 reports
-
Boston Scientific shares saw a fund cut stake, concurrent with Bank of America dropping its price objective, following an SEC filing.Some support1 report
-
Medtronic and Boston Scientific are expanding globally into emerging markets, operating in the MedSurg equipment space.Speculative1 report1 development inside
-
Medtronic and Boston Scientific are expanding operations across Europe and preparing for U.S. market entry through acquisitions and manufacturing collaborations.Some support1 report
-
Trump's pledge to unleash oil and gas is reported to benefit stocks, involving BTCS Inc.Some support3 reports1 development inside
-
Stifel cut price targets for Boston Scientific following study results presented at the American College of Cardiology meeting, with Matthew Taylor involved.Some support1 report
-
A Congressman recognized service in Johns Creek, where Boston Scientific has a site.Some support1 report
Gone quiet
No new reports in 90+ days-
A representative made multiple stock transactions on June 1, 2026, involving companies such as Ciena, HealthEquity, AutoZone, and SoftBank Group.Some support6 reports
-
Phibro Animal Health is a division of Phibro, which outperformed the S&P 500 this year.Some support6 reports
-
TD Cowen maintained a Buy rating on Boston Scientific on June 25, 2026.Some support1 report
-
Boston Scientific, led by Mahoney, benefits from tariffs associated with the Trump administration.Some support1 report
-
Company input drives vascular care reform in England.Some support1 report
-
Institutional investment activity in Boston Scientific reported to the SEC, involving Norges Bank and Morgan Stanley.Some support1 report
-
Boston Scientific is successfully expanding its base and reporting strong growth in the Asia Pacific region, including Europe and China.Some support1 report
-
Boston Scientific and J&J face charges due to Trump's trade strategy, while Stryker and Boston Scientific complete major acquisitions in the medtech sector.Speculative1 report
-
Johnson & Johnson, Boston Scientific, and Tempus AI are major medical device manufacturers and key players in AI-enabled medical devices.Some support1 report2 developments inside
-
Li Lu advised on investment risk factors, while Trump's policies were noted to benefit US stocks.Speculative1 report
-
Tariffs imposed by the Trump administration affected companies like Boston Scientific and Zimmer Biomet due to the trade tensions with China.Some support1 report
-
Parnassus Investments highlighted Boston Scientific as a stock poised to benefit from Trump-era tariffs.Speculative1 report
-
Zacks Investment Research provided stock analysis reports for Boston Scientific on June 20, 2025.Speculative1 report
-
Brainsway Ltd. and Boston Scientific operate in the medical device industry.Speculative1 report
-
Incepta Pharmaceuticals, Ensign Records, and Boston Scientific were classified into various medical industry groups in June 2025.Speculative1 report
-
Stryker Corporation and Boston Scientific, both medical device manufacturers, reported significant sales growth in the US and Asia-Pacific during Q2 2025.Speculative1 report
-
B&G Foods and Boston Scientific are being considered as stocks for investment.Speculative1 report
-
FDA approved the Farapulse system use, and the company anticipates further regulatory approvals in Europe and Japan. Analysts are bullish on the stock.Some support2 reports1 development inside
-
FDA granted expanded labeling approval for Boston Scientific's PFA System, with the company anticipating further regulatory approvals in Japan and China.Speculative1 report
-
ABR reflects analyst recommendations for Boston Scientific stock.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Boston Scientific this week
News at the entities that move Boston Scientific most-
Penumbra StructuralA tariff plan caused market tanking on August 22, 2025, impacting publicly traded companies including Golden Entertainment and AbbVie.Moves Boston Scientific
-
board of directors StructuralThe Coldwater Area Chamber of Commerce is seeking nominations for its leadership body.Moves Boston Scientific
-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Boston Scientific
-
SEC StructuralDHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Moves Boston Scientific
-
Norges Bank TransactionalNorges Bank bought a new position in Qualcomm shares, coinciding with buy ratings and price targets from TD Cowen, reported by MarketBeat.Moves Boston Scientific
-
Johnson & Johnson OperationalP&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Moves Boston Scientific
Connections
The 40 strongest of 209, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Penumbra Structural
Penumbra is a subsidiary of Boston Scientific following a $14.5bn acquisition completed in June 2026.
-
Mike Mahoney Structural
Mike Mahoney holds the executive leadership roles (Chairman and CEO) of Boston Scientific.
-
Mahoney Structural
Mahoney serves as the CEO and Chairman of Boston Scientific.
-
representative Transactional
The representative repeatedly purchased and sold shares of Boston Scientific during the observed period.
-
Mike Mahoney Structural
Mike Mahoney serves as the Chairman and CEO of Boston Scientific.
-
board of directors Structural
The board of directors holds formal governing authority over Boston Scientific, authorizing major financial actions like share buybacks.
-
FDA Structural
The FDA regulates Boston Scientific through market approvals, safety monitoring, and required alerts.
-
Johnson & Johnson Operational
Both companies are major competitors in the medical device and endoscopy markets.
Show all 40 connections
-
Cohen Transactional
Cohen's professional history is tied to Boston Scientific's M&A activity, specifically leading acquisitions like Axonics.
-
Gil Cisneros Transactional
Gil Cisneros purchased shares of Boston Scientific.
-
Abbott Laboratories Operational
Abbott Laboratories and Boston Scientific are direct competitors in the medical devices industry, vying for market share through innovation and strategic moves.
-
CrowdStrike Transactional
Boston Scientific engaged CrowdStrike to provide services for investigating a cyberattack.
-
Intuitive Surgical Operational
Both companies are major, leading competitors in the minimally invasive medical device market.
-
SEC Structural
Boston Scientific is subject to formal regulation by the SEC, requiring mandatory filings regarding its operations and incidents.
-
Danaher Corporation Operational
Both companies are leading manufacturers in the medical device industry and actively compete for market share.
-
Securities and Exchange Commission Structural
Boston Scientific operates under the mandatory regulatory oversight and filing requirements of the Securities and Exchange Commission.
-
McKesson Corporation Structural
McKesson supplies healthcare products, establishing a structural supply chain relationship with Boston Scientific.
-
New York Stock Exchange Structural
Boston Scientific operates and lists publicly on the New York Stock Exchange, making the exchange critical to its market presence.
-
Clonmel Structural
Clonmel serves as a manufacturing plant site for Boston Scientific in Ireland.
-
Stryker Corporation Operational
Stryker Corporation and Boston Scientific are direct competitors in the medical device and technology market.
-
Morgan Stanley Transactional
Morgan Stanley has increased and boosted its stock holdings in Boston Scientific.
-
Kardium (Canada) Structural
Kardium competes with Boston Scientific in the market while relying on Boston Scientific's devices as regulatory predicates for its own products.
-
Donald Trump Operational
Trump's political policies and trade strategies are shown to directly influence Boston Scientific's projected financial performance.
-
ABR Operational
ABR provides market analysis and investment recommendations regarding Boston Scientific stock.
-
Ahmed Abdelaal Structural
Ahmed Abdelaal serves as the Chief Marketing Officer for Boston Scientific in the Asia-Pacific region.
-
England Operational
The company's operational input is cited as a driver for specific vascular care reforms within England.
-
Cork Structural
Boston Scientific maintains a major operational plant in Cork, establishing a functional dependency on the location for its global operations.
-
MarketBeat Mentioned together
MarketBeat provides financial ratings and stock coverage for Boston Scientific.
-
Norges Bank Transactional
Norges Bank has purchased and invested in shares of Boston Scientific.
-
Latin America Operational
Boston Scientific conducts business and reports sales performance within the market of Latin America.
-
Medtronic plc Operational
The companies are direct competitors operating within the medical device manufacturing sector.
-
Ely Transactional
Boston Scientific committed funds to aid in the recovery efforts of Ely.
-
UnitedHealth Group Operational
Both companies are identified as major players operating within the competitive healthcare industry.
-
Georgia Transactional
Boston Scientific completed the acquisition of MiRus, which was based in Georgia.
-
Edwards Lifesciences Operational
Edwards Lifesciences and Boston Scientific are active competitors in the MedTech market, specifically regarding heart-valve systems.
-
Gilead Sciences Mentioned together
The entities are co-mentioned as leading companies within the medical sector.
-
Moderna Operational
The two companies are observed to operate in the competitive medical device market.
-
Stifel Mentioned together
Stifel provides sell-side research and commentary on Boston Scientific's corporate plans and performance.
-
Manufacturers Life Insurance Company Transactional
Manufacturers Life Insurance Company acquired a new position in Boston Scientific shares.
-
ARGUS Mentioned together
no direct coupling
History
Events by the month they beganSeptember 2026
6 events- Conavi Medical Corp. received FDA clearance for its system, which is used in the cardiovascular imaging sector.
- Shipping disruptions are causing procedural changes and increased competition among medical device manufacturers Johnson & Johnson and Boston Scientific.
- Both Dell Technologies and Boston Scientific were subject to analyst upgrades in May 2026.
- Boston Scientific filed an incident report with the SEC regarding a cyberattack and hired CrowdStrike to investigate.
- Boston Scientific and NovoCure are both facing cybersecurity incidents in 2026.
- David Gill, who holds an MBA from Emory University, was appointed Chair of Telix Board and previously worked for INC Research.
August 2026
18 events- Stryker Corporation, Boston Scientific, and Medtronic plc are competing in the medical device market.
- Boston Scientific is based in Massachusetts.
- Cyberattacks disrupted global operations of Boston Scientific, coinciding with the FDA raising concerns regarding product sheath tip separation.
- Boston Scientific is headquartered in Marlboro, Massachusetts.
- Boston Scientific's global operations, based in Ireland, are affected across its facilities in Cork, Clonmel, and Galway.
- Morgan Stanley boosted its position in Boston Scientific shares, while the company's board authorized a stock repurchase program.
- Raymond James Financial reissued an outperform rating and acquired a new position in Boston Scientific shares.
- Royal Bank of Canada and Leerink Partners lowered price targets and ratings for Boston Scientific.
- Norges Bank purchased a new position in shares of Boston Scientific.
- Demand for the Watchman heart device manufactured by Boston Scientific has slowed sharply in the U.S., due to competitive market share losses.
- A client successfully implemented leadership programs involving Boston Scientific, BTS Group AB, and Ernst & Young.
- Companies founded by Robert Schwartz led to the acquisition of the Watchman device.
- Analysts are comparing the business performance of two healthcare companies: Boston Scientific and Fielmann Group AG.
- The Child & Family Center was recognized for consistent support of children's services and sponsoring domestic violence and mental health programs.
- Gilead Sciences, Boston Scientific, McKesson Corporation, and Dexcom are listed as top medical stocks.
- Boston Scientific and TerrAscend compared their financial performance metrics on August 6, 2026.
- Analyst questions regarding Boston Scientific influenced management's guidance reset due to competitive threats in the U.S. market.
- Analyst downgrades and price target reductions affecting companies including GoDaddy, Boston Scientific, and Edison International.
July 2026
10 events- Intuitive Surgical, Boston Scientific, and Abbott Laboratories are major players in the global healthcare device sector.
- Boston Scientific announced major restructuring via filings with the NYSE and SEC on July 28, 2026.
- MarketBeat highlighted Boston Scientific as a stock to watch on July 29, 2026.
- Ahmed Abdelaal has been appointed as CMO for Boston Scientific in the APAC region, and the company commissioned a report on AFib care there.
- High confidence in PFA faces patient access gaps in the APAC healthcare market.
- Modular Medical, Inc., a San Diego-based medical device company, and Boston Scientific are both facing market scrutiny.
- Boston Scientific shares saw a fund cut stake, concurrent with Bank of America dropping its price objective, following an SEC filing.
- Medtronic and Boston Scientific are expanding operations across Europe and preparing for U.S. market entry through acquisitions and manufacturing collaborations.
- Stifel cut price targets for Boston Scientific following study results presented at the American College of Cardiology meeting, with Matthew Taylor involved.
- A Congressman recognized service in Johns Creek, where Boston Scientific has a site.
Show 1 earlier month
June 2026
26 events- Mike Mahoney was appointed chairman and CEO of Boston Scientific on July 1, 2025.
- Penumbra was acquired by Boston Scientific in a $14.5bn deal, and the company gained clearance for its Thunderbolt product line.
- Boston Scientific reported its financial results for the period ending August 2025, noting revenue increases across various regions.
- Boston Scientific and Avivagen are competing in the medical device market, with analysts using MarketBeat for ratings.
- Medtronic and Boston Scientific are expanding globally into emerging markets, operating in the MedSurg equipment space.
- Trump's pledge to unleash oil and gas is reported to benefit stocks, involving BTCS Inc.
- A representative made multiple stock transactions on June 1, 2026, involving companies such as Ciena, HealthEquity, AutoZone, and SoftBank Group.
- Phibro Animal Health is a division of Phibro, which outperformed the S&P 500 this year.
- TD Cowen maintained a Buy rating on Boston Scientific on June 25, 2026.
- Boston Scientific, led by Mahoney, benefits from tariffs associated with the Trump administration.
- Company input drives vascular care reform in England.
- Institutional investment activity in Boston Scientific reported to the SEC, involving Norges Bank and Morgan Stanley.
- Boston Scientific is successfully expanding its base and reporting strong growth in the Asia Pacific region, including Europe and China.
- Boston Scientific and J&J face charges due to Trump's trade strategy, while Stryker and Boston Scientific complete major acquisitions in the medtech sector.
- Johnson & Johnson, Boston Scientific, and Tempus AI are major medical device manufacturers and key players in AI-enabled medical devices.
- Li Lu advised on investment risk factors, while Trump's policies were noted to benefit US stocks.
- Tariffs imposed by the Trump administration affected companies like Boston Scientific and Zimmer Biomet due to the trade tensions with China.
- Parnassus Investments highlighted Boston Scientific as a stock poised to benefit from Trump-era tariffs.
- Zacks Investment Research provided stock analysis reports for Boston Scientific on June 20, 2025.
- Brainsway Ltd. and Boston Scientific operate in the medical device industry.
- Incepta Pharmaceuticals, Ensign Records, and Boston Scientific were classified into various medical industry groups in June 2025.
- Stryker Corporation and Boston Scientific, both medical device manufacturers, reported significant sales growth in the US and Asia-Pacific during Q2 2025.
- B&G Foods and Boston Scientific are being considered as stocks for investment.
- FDA approved the Farapulse system use, and the company anticipates further regulatory approvals in Europe and Japan. Analysts are bullish on the stock.
- FDA granted expanded labeling approval for Boston Scientific's PFA System, with the company anticipating further regulatory approvals in Japan and China.
- ABR reflects analyst recommendations for Boston Scientific stock.